When GlaxoSmithKline Plc (GSK) sent a top executive to Beijing this week to apologize in person for alleged corruption, he delivered a second pledge: cheaper drugs.
“We fully support the efforts of the Chinese authorities in their reforms of the medical sector,” Abbas Hussain, the London-based drugmaker’s president overseeing emerging markets, said in a statement on the website of the Ministry of Public Security, the country’s top law enforcer. Any savings in the way Glaxo operates, he said, will be passed to consumers, “ensuring our medicines are more affordable to Chinese patients.”
Read Full Article HERE
Bloomberg News via CHINA US Focus http://feedproxy.google.com/~r/ChinaUsFocus/~3/M0IIKrTA9lc/
No comments:
Post a Comment